Shuttle pharmaceuticals ipo

WebSep 1, 2024 · According to Shuttle Pharmaceuticals, the IPO has it set to raise $9.96 million in gross proceeds. Boustead Securities acted as the lead underwriter of the offering while … WebSep 6, 2024 · ROCKVILLE, Md., Sept. 6, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH ), a discovery and development stage specialty …

Shuttle Pharmaceuticals IPO Opens Shar…

WebMar 25, 2024 · Get undefined (SHPH.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments earool https://jocatling.com

www.sec.gov

WebAug 31, 2024 · Radiation therapy drug developer Shuttle Pharmaceuticals ( NASDAQ: SHPH) saw its stock soar 373% following its $10M initial public offering on Wednesday. Shares … WebSep 6, 2024 · September 6, 2024 - 9:00 am. ROCKVILLE, Md., Sept. 6, 2024-- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage … WebMar 15, 2024 · March 15, 2024 - 9:00 am. ROCKVILLE, Md., March 15, 2024-- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage … ct299

Shuttle Pharmaceuticals

Category:Shuttle Pharmaceuticals Holdings, Inc. has filed an IPO in the …

Tags:Shuttle pharmaceuticals ipo

Shuttle pharmaceuticals ipo

Shuttle Pharmaceuticals IPO Opens Shar…

WebAktien, Aktienkurse, Devisenkurse und Währungsrechner, Rohstoffkurse. Informationen rund um die Börse zu Aktie, Fonds und ETFs. Börsenkurse für Optionsscheine und Zertifikate. Aktienanalysen - finanzen.net WebMar 15, 2024 · ROCKVILLE, Md., March 15, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty …

Shuttle pharmaceuticals ipo

Did you know?

WebJul 1, 2024 · The last biotech to go public, eye drug developer Okyo Pharma, did so in mid-May and raised less than $3 million, according to BioPharma Dive’s database. Two biotechs, Genelux and Shuttle Pharmaceuticals, have publicly outlined IPO plans since the end of April, and they’ve joined a queue of companies mostly targeting modest offerings. WebDec 13, 2016 · Shuttle Pharmaceuticals plans to offer 4.5 million common shares in its IPO at a price of $8 per share.

WebMark is an experienced C-Level professional and the Founder & Chief Visionary Officer at NOUV, a management and financial consulting firm that offers an integrated solution across all business functions in consulting, business support and assurance services. Mark specialises in helping organisations identify, design, and execute their strategy. He has … WebShuttle Pharmaceuticals is a clinical-stage pharmaceutical company leveraging our proprietary technology to develop novel therapies that are designed to cure cancer. Our …

WebFeb 17, 2024 · Shuttle Pharmaceuticals Holdings, Inc. Common Stock (SHPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. WebAug 30, 2024 · Aug 30, 2024, 16:40 ET. ROCKVILLE, Md., Aug. 30, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH ), a discovery and development …

WebApr 11, 2024 · Accédez à toutes les dernières informations boursières et économiques en France, aux Etats-Unis, et en Europe.

Web哪里可以找行业研究报告?三个皮匠报告网的最新栏目每日会更新大量报告,包括行业研究报告、市场调研报告、行业分析报告、外文报告、会议报告、招股书、白皮书、世界500强企业分析报告以及券商报告等内容的更新,通过最新栏目,大家可以快速找到自己想要的内容。 earosol isolatieWebShuttle Pharmaceuticals Holdings Inc. shares were up 35%, to $20.04, after the company said its initial public offering of 1.23 million units of common stock and warrants at $8.13 … earotary.orgWebMar 15, 2024 · Shuttle Pharmaceuticals Holdings, Inc. ... ("IPO") raising gross proceeds of $11.5 million, inclusive of the overallotment option, listing its common stock on the … ear originWebShuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and ... ct2 9abWebAug 31, 2024 · Today's IPO for Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) opened for trading at $24.05 after pricing 1,225,888 units of common stock and warrants, … ear ossificationWebApr 5, 2024 · Shuttle Pharmaceuticals Shuttle Pharmaceuticals Holdings, Inc (NASDAQ: SHPH) is a discovery and development stage specialty pharmaceutical company focusing on cancer treatments and radiation therapy. Their Sept 2024 IPO was valued at just under $10 million at a share price of $8.125. ct2 9atWebJun 6, 2024 · Shuttle Pharmaceuticals Holdings ( NASDAQ: SHPH) has filed to raise $14.25 million in an IPO of its common stock, according to an S-1 registration statement. The … ear oroblem caused death